We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
Nomura on HCL Tech: Buy | Target price: Rs 1,720
Nomura has maintained a buy call on HCL Tech and hiked the target price to Rs 1,720 from Rs 1,700.
Q1FY25 was a slight beat to estimates. GenAl impact is likely to vary across service lines and the company is on track to achieve FY25F revenue growth guidance.
Investec on HCL Tech: Sell | Target price: Rs 1,312
Investec has maintained a sell view on HCL Tech and hiked the target price to Rs 1,312 from Rs 1,300.
The first quarter was inline. The impact of Gen Al is quantifiable and is a net gainer for now. However, the primary concern is EBIT% being at the bottom of the guided band.JPMorgan on Avenue Supermarts: Overweight | Target price: Rs 5,400
The global brokerage has maintained an overweight call on Avenue Supermarts with a target price of Rs 5,400.The company delivered a robust revenue growth delivery with an encouraging mix bodes well for gross margin trajectory. Best growth engine amongst discretionary names, which should support premium valuations.BofA on Avenue Supermarts: Buy | Target price: Rs 5,465
Bank of America has maintained a buy with a target price of Rs 5,465.
Q1FY25 was a stable quarter, and improving G&A contribution was positive. The business momentum is likely to remain healthy and efforts on increasing store footprint across core states of Maharashtra/Gujarat as well as other markets can be seen.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
